Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
Open Access
- 1 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Crohn’s & Colitis 360
- Vol. 3 (1) , otab007
Abstract
Background: Understanding ulcerative colitis disease activity assessed via the full, modified, or partial Mayo Score may help clinicians apply results from clinical trials to practice and facilitate interpretation of recent and older studies.Methods: Mayo Score variables were assessed in a cross-sectional study of 2608 ulcerative colitis patients.Results: Permutations of Mayo Scores were highly correlated, and models predicting the omitted variable from each permutation demonstrated significant agreement between predicted and observed values.Conclusions: Partial/modified Mayo Scores may be used to predict endoscopic and Physician’s Global Assessment scores, and serve as proxies for the full Mayo Score in clinical practice/trials.Keywords
Funding Information
- Eli Lilly and Company
This publication has 24 references indexed in Scilit:
- Ulcerative ColitisMayo Clinic Proceedings, 2014
- Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2014
- Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyFrontline Gastroenterology, 2014
- Ulcerative ColitisNew England Journal of Medicine, 2011
- Practice Patterns in the Use of Anti-Tumor Necrosis Factor Alpha Agents in the Management of Crohn’s Disease: A US National Practice Survey Comparing Experts and Non-ExpertsDigestive Diseases and Sciences, 2010
- Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in GermanyInflammatory Bowel Diseases, 2010
- Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative ColitisInflammatory Bowel Diseases, 2008
- Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understandCurrent Medical Research and Opinion, 2008
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987